19 drug(s) with this reaction
14,889 total reports
Insomnia has been reported as an adverse reaction across 19 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 14,889 adverse event reports mention insomnia in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with insomnia, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have insomnia listed in their FDA adverse event reports, sorted by report count:
In addition to insomnia, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
19 drug(s) manufactured by Haleon Us Holdings Llc have insomnia listed in their FDA adverse event reports: DICLOFENAC SODIUM, FLUTICASONE PROPIONATE, CALCIUM CARBONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, NICOTINE, and others.
There are a combined 14,889 reports of insomnia across 19 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.